Gene Query: PDGFD

Dataset Description Geneva Score
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 170.0
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 96.2
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 74.44
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 70.45
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 70.45
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 59.38
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 57.24
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 52.94
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 47.53
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 47.05
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 46.97
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 46.06
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 43.74
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 43.74
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 42.16
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 37.88
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 37.88
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 36.89
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 36.8
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 34.16
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 33.57
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 31.49
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 30.35
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 29.3
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 27.33
Differential gene expression in Jagged1 treated human dental pulp cells. 26.99
Expression by CD133+ cells isolated from the adult human exocrine pancreas 26.59
Regionally specified human pluripotent stem cell-derived astrocytes 26.48
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 25.76
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 25.76
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 25.17
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 25.06
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 24.62
Transcriptional profiles of normal human mature B cells 23.1
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 22.36
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 21.72
Transcriptome of U251 cells overexpression complement component 7 21.5
Transcriptomic and gene ontology profiling of the human corneal cell types 21.46
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 20.91
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 20.24
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 19.97
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 19.59
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 19.56
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 19.19
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 18.67
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 18.49
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 18.11
PGE2 mediated gene expression changes in human cervical stromal cells 18.05
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 18.0
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 17.88
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 17.88
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 17.78
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 17.69
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 17.53
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 17.52
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 17.37
RNA-Seq from early time points in the kidney differentiation protocol 17.31
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 17.26
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 17.26
Gene expression profile of human iPSC-derived nephron progenitor cells 17.1
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 17.05
Differential expression of genes in AD169-infected MRC5. 16.93
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 16.44
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 16.05
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 15.79
MYCL and EP400 are required for Max and MCPyV mediated gene activation 15.19
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 15.14
Widespread intronic polyadenylation diversifies immune cell transcriptomes 14.98
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  14.72
Expression level comparison under dividing and quiescent states in human primary fibroblasts 14.58
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 14.48
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 14.15
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 13.88
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 13.85
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 13.79
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 13.64
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 13.58
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 13.14
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 13.06
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 13.03
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 13.03
Differential analysis of gene regulation at transcript resolution by RNA-Seq 12.94
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 12.94
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 12.78
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 12.71
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 12.5
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 12.5
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 12.39
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 12.38
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 12.2
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 12.2
TGF-β promotes genomic instability after loss of RUNX3 12.13
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 11.86
Expression profiling of etoposide-induced senescent cells 11.82
RNA-seq of human fibroblasts after irradiation 11.45
High-Throughput Kinetic Analysis of Fractional Killing 11.39
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 11.27
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 11.14
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 11.03
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 11.0
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 10.88
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 10.84
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 10.6
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 10.44
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 10.37
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 10.28
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 10.2
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 10.03
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 9.9
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 9.9
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 9.84
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 9.75
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 9.67
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 9.66
RNA-seq in HepG2 and IMR90 cells 9.59
Evolution of a transcriptional regulator from a transmembrane nucleoporin 9.59
Expression data from miR340 overexpressing human A549 cells 9.49
Identification of Sin3B regulated genes during quiescence 9.42
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 9.29
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 9.16
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 9.06
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 9.05
Nonpregnant and term pregnant human myometrial tissues 9.05
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 8.99
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 8.89
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 8.64
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 8.58
Chromatin landscape of human visceral and subcutaneous adipocytes 8.52
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 8.52
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 8.52
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 8.49
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 8.49
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 8.47
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 8.29
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 8.19
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 8.19
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 8.19
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 8.07
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 8.03
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 8.03
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 7.86
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 7.84
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 7.83
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 7.83
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 7.82
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 7.81
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 7.76
EP400 is required for Max and MCPyV mediated gene activation 7.75
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 7.6
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 7.59
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 7.57
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 7.54
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 7.51
MicroRNA targetome analysis during HCMV infection 7.5
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 7.49
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 7.48
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 7.48
The gene expression profiles of gallbladder cancer 7.39
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 7.34
Human islets of varying quality: the good, the (not so) bad and the ugly 7.33
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 7.33
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 7.31
Single cell transcriptome of peritoneal cells 7.26
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 7.03
Epigenetic reprogramming of melanoma cells by vitamin C treatment 6.99
RNA seq comparison between scrambled and shGRP78 cells 6.98
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 6.9
Transcriptional responses of human insulinoma cells to acute cytokine exposure 6.75
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 6.7
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 6.68
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 6.55
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 6.54
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 6.43
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 6.41
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 6.38
Transcriptome analysis of H9 hESC derived cerebral organoids 6.31
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 6.26
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 6.18
RNA-Seq from human ILC transitional populations 6.18
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 6.14
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 6.13
Random mono-allelic expression in MECP2-mutated cells 6.1
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 6.1
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 6.05
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 6.03
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 5.87
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 5.83
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 5.81
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 5.78
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.71
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 5.55
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 5.55
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 5.55
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 5.55
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 5.54
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 5.5
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 5.49
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 5.47
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 5.46
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 5.42
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 5.42
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 5.39
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 5.39
Morphological and molecular characterization of human dermal lymphatic collectors 5.37
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 5.32
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 5.32
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 5.3
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 5.29
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 5.26
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 5.22
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 5.22
Effect of Hotair overexpression in human breast cancer cell lines 5.11
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 5.1
Gene expression alterations of pancreatic intraepithlial neoplasia 5.07
Exploring ILF2 regulatory genes by next-generation sequencing 5.06
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 5.01
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 5.0
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 4.97
ChIP-seq and RNA-seq from human lymphoma cell lines 4.89
RNA-seq data from human lymphoma cell lines 4.89
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 4.72
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 4.7
Genome-wide analysis of Dengue virus 2 infected cells 4.67
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 4.62
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 4.6
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 4.6
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 4.59
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 4.59
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 4.58
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 4.56
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 4.56
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.52
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 4.48
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 4.41
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 4.41
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 4.41
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 4.4
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 4.36
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 4.35
RNA-seq of stable and unstable section of human atherosclerotic plaques 4.34
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 4.32
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 4.27
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 4.23
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 4.18
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 4.17
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 4.16
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 4.14
Effect of PRDM11 depletion in U2932 cells 4.13
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 4.12
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 4.12
Investigation about fibroblasts of different origins in culture 4.06
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 4.05
The expression profiles of GBC liver metastasis 4.04
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 3.96
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 3.96
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 3.88
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 3.85
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 3.84
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 3.84
RNA Sequencing of Human iPS derived Cardiomyocytes 3.83
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 3.81
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 3.79
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 3.79
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 3.75
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 3.75
Dynamic reorganization of nuclear architecture during human cardiogenesis 3.75
High-efficiency RNA-based reprogramming of human primary fibroblasts 3.72
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 3.68
Comparing gene expression in iPSC derived RPE from control and AMD donors 3.67
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 3.66
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 3.65
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 3.65
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 3.59
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 3.57
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 3.56
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 3.56
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 3.55
FOXP2's impact on the primate transcriptome 3.55
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 3.55
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 3.51
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 3.5
A549 cells and MSR-A549 cells 3.5
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 3.5
RNA-sequencing in irradiated and normal A549 cells. 3.43
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 3.42
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 3.42
Identification of Nrf2 regulated genes by RNA sequencing 3.41
Nrf2 regulated genes in A549 cells 3.41
Transcriptome profiling of 5 human adenocarcinoma cell lines 3.34
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 3.31
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 3.26
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 3.25
Transcriptome of human white and brown adipose tissue biopsies 3.22
Hepatosplenic T cell lymphoma 3.21
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 3.21
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 3.2
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 3.2
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 3.16
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 3.16
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 3.13
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 3.13
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 3.13
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 3.12
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 3.1
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 3.08
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 3.07
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 3.06
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 3.02
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 2.94
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 2.93
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 2.93
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 2.93
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 2.93
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 2.9
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 2.9
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 2.9
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 2.9
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 2.89
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 2.86
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.86
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.86
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.84
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 2.83
Modeling Familial Cancer with iPSC Approaches 2.8
Characterization of human ILC2 subsets 2.79
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 2.74
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 2.71
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 2.69
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 2.68
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 2.67
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 2.64
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 2.64
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 2.62
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 2.62
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 2.59
mRNA expression profile of Lymphocytes by high-throuput sequencing 2.57
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 2.56
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 2.53
Activity-dependent transcriptional changes in human neurons 2.48
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 2.46
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 2.45
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 2.42
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 2.42
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 2.41
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 2.4
Gene expression signatures of innate lymphoid cells from human blood 2.39
Gene expression profiling of human and murine in vitro muscle differentiation 2.39
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 2.39
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.38
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.38
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 2.36
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 2.34
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.29
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.29
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 2.27
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 2.27
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 2.19
BMS-470539 on human synovial fibroblasts 2.19
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 2.18
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 2.17
Fibroblasts in cholesteatoma activate osteoclasts. 2.16
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 2.14
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 2.14
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 2.09
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 2.05
2.05
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 2.03
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 2.03
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 2.03
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 2.0
RNA-seq analysis upon ARID1B overexpression 1.96
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 1.96
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 1.95
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 1.93
mRNA-sequencing of breast cancer subtypes and normal tissue 1.9
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.9
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 1.89
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 1.89
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.89
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 1.89
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 1.85
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 1.79
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.76
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 1.75
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 1.75
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 1.74
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 1.74
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.7
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 1.69
A549 cell transcriptome responses to infection with H7N9 influenza virus 1.68
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.66
Redifferentiation of expanded human islet β cells by inhibition of ARX 1.63
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 1.59
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.56
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.54
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.54
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.54
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 1.53
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.52
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.52
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 1.51
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 1.51
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.49
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.46
CD74 role in transcription regulation 1.46
CD74 role in transcription regulation [RNA-seq] 1.46
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 1.44
IL-33 activates tumor stroma to promote intestinal polyposis 1.44
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 1.44
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 1.43
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 1.37
CUREfast: Accelerating research with families 1.36
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 1.32
The conserved transcriptional landscapes in human spermatogenesis 1.31
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 1.31
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.29
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.25
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.23
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 1.22
The transcriptome of Kawasaki Disease arteritis 1.17
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 1.17
Gene expression profile of CRC-derived HILEC 1.17
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 1.16
Total RNA-Seq data from leukemic patients with complex structural variants 1.15
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 1.14
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.11
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 1.1
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 1.03
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.02
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.02
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 1.0
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.97
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.97
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.93
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 0.91
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 0.9
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 0.89
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 0.89
SF3B1 Degron knockdown RNA-seq 0.86
Transcriptome-wide response to synthetic chromatin protein PcTF 0.83
The DNA methylation landscape of human melanoma 0.81
The DNA methylation landscape of human melanoma [RNA-Seq] 0.81
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.77
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 0.77
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 0.77
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 0.76
Identification of a LIF-responsive replication-competent human β cell 0.76
Epigenome regulation during epidermal lineage commitment 0.74
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.72
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.72
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.68
RNA-Seq in PWS iPSC-derived neurons 0.65
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.65
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.65
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.63
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 0.62
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 0.58
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 0.58
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  0.56
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 0.54
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 0.54
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.54
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.54
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.53
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 0.52
RNA-seq in endometrial stromal tumors 0.5
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.47
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.46
BET bromodomain inhibition 0.46
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 0.46
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 0.41
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.39
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 0.37
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.36
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.36
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.35
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.28
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.28
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 0.27
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 0.27
Engineering Patient-Specific Tissue Implants 0.26
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.26
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 0.25
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.25
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.22
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 0.21
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 0.21
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 0.19
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.17
Expression patterns in chronic thromboembolic pulmonary hypertension 0.15
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.13
Gene expression profiling of KSHV-infected periodontal ligament cells 0.12
RNA-Seq and expression data from human adipose tissue 0.11
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.11
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.1
Transcriptomic analysis of frontal fibrosing alopecia 0.09
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.09
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.05
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 0.03
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation